BRPI0916131A2 - método de preparação de derivados do ácido hialurônico e uso de um derivado obtido pelo método - Google Patents

método de preparação de derivados do ácido hialurônico e uso de um derivado obtido pelo método

Info

Publication number
BRPI0916131A2
BRPI0916131A2 BRPI0916131A BRPI0916131A BRPI0916131A2 BR PI0916131 A2 BRPI0916131 A2 BR PI0916131A2 BR PI0916131 A BRPI0916131 A BR PI0916131A BR PI0916131 A BRPI0916131 A BR PI0916131A BR PI0916131 A2 BRPI0916131 A2 BR PI0916131A2
Authority
BR
Brazil
Prior art keywords
hyaluronic acid
acid derivatives
derivative obtained
preparing hyaluronic
preparing
Prior art date
Application number
BRPI0916131A
Other languages
English (en)
Inventor
Lukas Palek
Martin Pravda
Radovan Buffa
Sofiane Kettou
Vladimir Velebny
Original Assignee
Cpn Spol Sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cpn Spol Sro filed Critical Cpn Spol Sro
Publication of BRPI0916131A2 publication Critical patent/BRPI0916131A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0916131A 2008-11-06 2009-11-05 método de preparação de derivados do ácido hialurônico e uso de um derivado obtido pelo método BRPI0916131A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20080705A CZ2008705A3 (cs) 2008-11-06 2008-11-06 Zpusob prípravy DTPA sítovaných derivátu kyseliny hyaluronové a jejich modifikace
PCT/CZ2009/000131 WO2010051783A1 (en) 2008-11-06 2009-11-05 Method of preparation of dtpa crosslinked hyaluronic acid derivatives and modification of said derivatives

Publications (1)

Publication Number Publication Date
BRPI0916131A2 true BRPI0916131A2 (pt) 2015-11-03

Family

ID=41694684

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0916131A BRPI0916131A2 (pt) 2008-11-06 2009-11-05 método de preparação de derivados do ácido hialurônico e uso de um derivado obtido pelo método

Country Status (9)

Country Link
US (1) US20110218331A1 (pt)
EP (1) EP2350135A1 (pt)
JP (1) JP2012507615A (pt)
KR (1) KR20110082609A (pt)
BR (1) BRPI0916131A2 (pt)
CA (1) CA2742428A1 (pt)
CZ (1) CZ2008705A3 (pt)
RU (1) RU2011121239A (pt)
WO (1) WO2010051783A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010163485A (ja) * 2009-01-13 2010-07-29 Teijin Ltd カルボキシ多糖類の溶液
CZ2009836A3 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
KR101480393B1 (ko) * 2011-10-13 2015-01-09 전남대학교병원 간암 진단을 위한 조영제용 가돌리늄 착물과 이를 이용한 간암 진단용 조영제
CZ2012136A3 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
CZ2012282A3 (cs) * 2012-04-25 2013-11-06 Contipro Biotech S.R.O. Zesítovaný derivát hyaluronanu, zpusob jeho prípravy, hydrogel a mikrovlákna na jeho bázi
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
CZ305153B6 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ2015398A3 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
US20190264008A1 (en) * 2016-10-31 2019-08-29 Kewpie Corporation Gel Composition and Method for Producing Same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE456346B (sv) 1984-07-23 1988-09-26 Pharmacia Ab Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
US4582865A (en) 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
GB8519416D0 (en) 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
US4937270A (en) 1987-09-18 1990-06-26 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US5783691A (en) 1989-02-08 1998-07-21 Biomatrix, Inc. Crosslinked hyaluronate gels, their use and method for producing them
JP3563440B2 (ja) 1994-05-16 2004-09-08 生化学工業株式会社 アシル化ヒアルロン酸の製造法
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5789462A (en) 1995-09-13 1998-08-04 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Photocured crosslinked-hyaluronic acid contact lens
WO1997018224A1 (en) 1995-11-13 1997-05-22 Human Genome Sciences, Inc. Human stem cell antigen 2
DE19604706A1 (de) * 1996-02-09 1997-08-14 Merck Patent Gmbh Vernetzungsprodukte von Aminogruppen-haltigen Biopolymeren
GB9902652D0 (en) 1999-02-05 1999-03-31 Fermentech Med Ltd Process
EP1217008B1 (en) 2000-12-19 2006-03-01 Seikagaku Corporation Photocurable hyaluronic acid derivative and process for producing the same, and photocured crosslinked hyaluronic acid derivative and medical material using the same
US6673919B2 (en) * 2001-03-30 2004-01-06 Chisso Cororation Chemically modified hyaluronic acid or salts thereof, and a process for producing thereof
JP3975267B2 (ja) * 2002-06-03 2007-09-12 独立行政法人産業技術総合研究所 多糖物質のアシル化方法
ITMI20022745A1 (it) 2002-12-23 2004-06-24 Coimex Scrl United Companies Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione.
JP4745826B2 (ja) 2003-11-14 2011-08-10 中外製薬株式会社 架橋多糖微粒子およびその製造方法
US8124120B2 (en) 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
ITRM20040318A1 (it) 2004-06-28 2004-09-28 Univ Palermo Idrogeli di acido ialuronico e alfa, beta-poliaspartilidrazide e loro applicazioni in campo biomedico e farmaceutico.
WO2007129828A1 (en) 2006-05-04 2007-11-15 Seoul National University Industry Foundation Preparation method of porous hyaluronic acid sponge for cell delivery system
CZ302856B6 (cs) * 2006-09-27 2011-12-14 Cpn Spol. S R. O. Zpusob prípravy derivátu polysacharidu

Also Published As

Publication number Publication date
KR20110082609A (ko) 2011-07-19
WO2010051783A1 (en) 2010-05-14
CZ301555B6 (cs) 2010-04-14
EP2350135A1 (en) 2011-08-03
US20110218331A1 (en) 2011-09-08
CA2742428A1 (en) 2010-05-14
JP2012507615A (ja) 2012-03-29
RU2011121239A (ru) 2012-12-20
CZ2008705A3 (cs) 2010-04-14

Similar Documents

Publication Publication Date Title
BRPI0916131A2 (pt) método de preparação de derivados do ácido hialurônico e uso de um derivado obtido pelo método
BR112015002755A2 (pt) derivado de ácido hialurônico, método de preparação de derivado de ácido hialurônico, método de modificação de derivado de ácido hialurônico e uso de derivados
BR112012019936A2 (pt) uso de um composto, método de preparação de um composto, método e composto
BRPI0907119A2 (pt) Derivados de insulina tendo um perfil de ação de tempo extremamente retardado
DK2370474T3 (da) Fremgangsmåde til fremstilling af hyaluronsyrefunktionaliserede derivater og dannelse af hydrogeler deraf
BRPI0922174A2 (pt) preparação farmacêutica, uso de uma preparação, e, método para preparar uma preparação farmacêutica
BRPI0920145A2 (pt) compostos de tioamida, método de produção e método de uso dos mesmos
BR112013011997A2 (pt) "métodos para produzir uma solução aquosa concentrada de açúcar e para produzir etanol como uso de uma levedura"
BRPI1010774A2 (pt) método de uso de particulados.
BR112013014598A2 (pt) composição imunogênica, uso de uma composição imunogênica, processo para preparar uma composição imunogênica, método para a fabricação de uma composição imunogênica estável, e, kit
BRPI1010668A2 (pt) sensor ótico de método de uso
BRPI0913109A2 (pt) solução aquosa oftálmica, uso de análogos de pgf2a, e, método para aumentar a solubilidade em água e melhorar a estabilidade de análogos de pgf2a em uma solução aquosa oftálmica
BR112012013955A2 (pt) método de preparação de um derivado oxidado de ácido hialurônico e método de modificação do derivado de ácido hialurônico
BRPI0823082A2 (pt) Uso derivados de sesquiterpeno
BRPI1010775A2 (pt) composição, método para preparar uma composição, e, uso de uma composição.
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
BR112012013954A2 (pt) derivado de ácido hialurônico, método de preparação do derivado de ácido hialurônico e método de modificação do derivado de ácido hialurônico
BRPI0913833A2 (pt) uso de corantes ácidos
BR112012001998A2 (pt) solução oftálmica, uso de um composto, e, método para preparação de uma solução oftálmica.
BRPI0908252A2 (pt) Processo para preparar um composto, e, uso de um composto
IT1392524B1 (it) Metodo per misure radar interferometriche
BRPI0907298A2 (pt) preparação solúvel em água, método para produzir uma preparação e uso de uma preparação
BR112013013696A2 (pt) método para preparar uma levedura industrial, levedura industrial e uso na produção de etanol a partir de pelo menos uma pentose
BR112012004173A2 (pt) "composto, composição, método para preparar uma composição, e, uso de um composto"
ATE545635T1 (de) Substituierte n-oxidpyrazinderivate

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: CPN SPOL. S.R.O. (CZ)

Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 18120046746, DE 18/12/2012, E NECESSARIO APRESENTAR O DOCUMENTO NOTARIZADO E COM A DEVIDA LEGALIZACAO CONSULAR.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B25E Requested change of name of applicant rejected

Owner name: CPN SPOL. S.R.O. (CZ)